Angiogenesis
Studies from University College provide new data on angiogenesis
Published in Cancer Weekly, August 14th, 2007
According to a study from Dublin, Ireland, "The inhibition of angiogenesis, defined as the process of new blood vessel formation, represents a promising strategy for treating cancer. The inhibitory properties of two N-(per-O-acetylated-beta-D-mannopyranosyl)-thiophene-2-carboxamides derivatives (AMTCs, [1],[2]), N(2,3,4,6-tetra-O-ethoxycarbonyl-beta-D-mannopyranosyl)-thiophene2-carboxamide [3] and of 2,3,4,6-tetra-O-acetyl-beta-D-mannopyranosyl-acetamide [4] on the growth of bovine aortic endothelial cells (BAECs) induced by basic fibroblast growth factor (bFGF) were assessed using a [H-3]thymidine incorporation assay. The cellular uptake of AMTCs and the non-acetylated homologue (MTC)...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-08-14)
More Articles from Cancer Weekly
- Brain Cancer
Peregrine Pharmaceuticals Doses First Patient in Cotara Phase II Brain Cancer Trial In India - Breast Cancer
Biofield Signs Master License Agreement with the MacKay Group to Distribute, Manufacture, Develop and Commercialize the Biofield Breast Cancer Diagnostic System (BDS) - Breast Cancer
Chicagoland Affiliate of Susan G. Komen for the Cure, State Lawmakers, Breast Cancer Survivors, Faith Leaders Rally for Action on Breast Cancer - Breast Cancer
Hooters Donates $250,000 to the V Foundation for Cancer Research Towards Kelly Jo Dowd Breast Cancer Research Grant - Breast Cancer
National Breast Cancer Foundation Unveils Innovative Web Site for Survivors - Breast Cancer
Power3 Medical Products, Inc. Provides Results from 60 Patient Blinded Validation Study of BC-SeraPro - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
